Vassallo, C., B. Canali, F. Fiorentino, P. Morelli, S. Ripoli, and L. Fioravanti. “Brentuximab Vedotin + AVD in CHL: Cost Impact on Adverse Events, Toxicity, Second Malignancies, End-of-Life and Subsequent Lines of Therapy in Italy”. AboutOpen, vol. 10, no. 1, Oct. 2023, pp. 103-9, doi:10.33393/ao.2023.2609.